abha@qu-consulting.com
+1-732-858-2299
Home
About
Practices
Open menu
Compliance
Regulatory Affairs
Science And Technology
Blogs
Contact
X
Contact Us
The U.S. Food and Drug Administration approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in adults.
The U.S. Food and Drug Administration approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in adults.